UB spinoff Cytocybernetics receives funding to accelerate COVID-19 drug
As COVID-19 infection rates and death tolls continue to rise, researchers and scientists around the world are racing to clear candidate drug therapies for COVID-19.UB spinoff…
Read More...
Read More...